Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of CANF will rise by +5.99% over the next 2 Weeks and hit $3.44 by Wednesday, July 22, 2026. In that time frame, CANF's share price is expected to range between $2.99 and $3.89.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Jul 22, 2026 | 2.99 | 3.44 | 3.89 |
| Jul 21, 2026 | 2.81 | 3.27 | 3.74 |
| Jul 20, 2026 | 2.89 | 3.33 | 3.76 |
| Jul 17, 2026 | 2.82 | 3.26 | 3.71 |
| Jul 16, 2026 | 2.91 | 3.37 | 3.81 |
| Jul 15, 2026 | 3.01 | 3.45 | 3.90 |
| Jul 14, 2026 | 2.84 | 3.27 | 3.74 |
| Jul 13, 2026 | 2.90 | 3.33 | 3.75 |
| Jul 10, 2026 | 2.85 | 3.26 | 3.73 |
| Jul 9, 2026 | 2.88 | 3.37 | 3.83 |
CANF shares rose +0.62% in Thursday, July 9, 2026's trading session, rising from a previous close of $3.25 to move at $3.27. The stock demonstrated notable intraday movement (see CANF's key stats for a full breakdown), fluctuating between $3.27 and $3.40, a +3.98% trading range. While recent weeks have seen some volatility, CANF has managed to secure a +11.22% gain over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 41.61K shares changing hands, 41.35K fewer than the previous session. This amounted to $136.05K in total market activity.
Will CANF Continue Its Upward Trend?
According to analyst ratings and projections for CANF, Can-Fite BioPharma Ltd. shares are anticipated to increase by +15.91%, potentially reaching $3.89 per share by July 22, 2026. Short-term technical indicators currently suggest a neutral sentiment for CANF. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 12 positive trading days within the past 30 sessions. Based on the CANF stock forecast, now is a good time to buy CANF stock because its current trading price is -5.07% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on CANF covering social and institutional perspectives.
CANF Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into CANF's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 48.78% to 50.12%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 46.53%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 42.78%, maintains a neutral outlook for the long term. Insights into CANF's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Can-Fite BioPharma Short-Term Forecasts
CANF Forecast For Next 5 Days
Our algorithm anticipates Can-Fite BioPharma (CANF) stock could hit $3.26 by Jul 16, 2026. This represents a -0.36% fall from today's price, following a -6.12% change over the past five days.
CANF Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Can-Fite BioPharma Ltd. (CANF) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $3.42, which would mean a +4.59% increase from the current price of $3.27. Projections for this period range from a high of $4.40 to a low of $2.80.
CANF Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Can-Fite BioPharma's price over the next three months point to a drop. CANF stock is expected to peak at $33.00 on Jul 15, 2026 before potentially dipping to $0.00 on Oct 09, 2026. On average, CANF is likely to trade around $3.08 in the coming 90 days.
Can-Fite BioPharma Stock Forecast 2025
Based on our predictive models, Can-Fite BioPharma (CANF) is expected to trade between $0.00 and $33.00 throughout 2026. This would result in an average price of $1.93, potentially offering investors a -40.98% return from current levels.
Can-Fite BioPharma Ltd. Monthly Forecast 2026–2027
July 2026
According to our latest forecast models, Can-Fite BioPharma Ltd. (CANF) is positioned to show a strong performance in July 2026. The price is predicted to move between $0.00 and $33.00, settling at an average of $5.90. This could translate to a +80.43% gain.
August 2026
Based on current market signals, Can-Fite BioPharma Ltd. is projected to trend august 2026. We forecast a trading range from $0.00 to $30.64, with a likely average price of $3.31. Investors could expect a potential return of +1.22%.
September 2026
Our predictive algorithms indicate Can-Fite BioPharma Ltd. stock may see a shift in September 2026. The expected range spans $0.00–$31.87, with an average target of $1.44. This represents a cautious outlook and a possible loss of -55.96%.
October 2026
Analyzing established trends, Can-Fite BioPharma Ltd. looks set to move in October 2026. Projections place the stock between $0.00 and $27.26, averaging around $1.20. This suggests a -63.30% loss from current levels.
November 2026
Market indicators suggest Can-Fite BioPharma Ltd. could experience notable changes during November 2026. Prices could fluctuate within $0.00 to $29.87, with a midpoint forecast of $0.63. The stock might deliver a -80.73% loss.
December 2026
Forecasting for December 2026, models estimate that Can-Fite BioPharma Ltd. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $30.11, averaging $0.25. This signals a cautious trajectory with potential returns around -92.35%.
January 2027
According to our latest forecast models, Can-Fite BioPharma Ltd. (CANF) is positioned to show a strong performance in January 2027. The price is predicted to move between $0.00 and $28.28, settling at an average of $0.26. This could translate to a -92.05% loss.
February 2027
Based on current market signals, Can-Fite BioPharma Ltd. is projected to trend february 2027. We forecast a trading range from $0.00 to $28.46, with a likely average price of $0.08. Investors could expect a potential return of -97.55%.
March 2027
Our predictive algorithms indicate Can-Fite BioPharma Ltd. stock may see a shift in March 2027. The expected range spans $0.00–$27.96, with an average target of $0.19. This represents a cautious outlook and a possible loss of -94.19%.
April 2027
Analyzing established trends, Can-Fite BioPharma Ltd. looks set to move in April 2027. Projections place the stock between $0.00 and $28.97, averaging around $0.08. This suggests a -97.55% loss from current levels.
May 2027
Market indicators suggest Can-Fite BioPharma Ltd. could experience notable changes during May 2027. Prices could fluctuate within $0.00 to $30.97, with a midpoint forecast of $0.08. The stock might deliver a -97.55% loss.
June 2027
Forecasting for June 2027, models estimate that Can-Fite BioPharma Ltd. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $28.24, averaging $0.12. This signals a cautious trajectory with potential returns around -96.33%.
July 2027
According to our latest forecast models, Can-Fite BioPharma Ltd. (CANF) is positioned to show a strong performance in July 2027. The price is predicted to move between $0.00 and $28.14, settling at an average of $0.08. This could translate to a -97.55% loss.
CANF's history of dividends and stock splits also plays a role in long-term investor confidence.